Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-14

Clinical Trial Update: Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States [Phase 4]

View source ↗

Summary

Phase 4 study evaluating effectiveness and safety of tezepelumab in adults and adolescents with severe asthma; the trial status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tezepelumab (tezepelumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 4 | Status: COMPLETED